These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8108881)

  • 1. Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens.
    Roelen DL; van Bree SP; van Beelen E; Schanz U; van Rood JJ; Claas FH
    Transplantation; 1994 Feb; 57(3):446-50. PubMed ID: 8108881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors.
    Zhang L; van Bree S; van Rood JJ; Claas FH
    Transplantation; 1990 Dec; 50(6):1008-10. PubMed ID: 2256142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.
    Roelen DL; Stobbe I; Young NT; van Bree SP; Doxiadis II; Oudshoorn M; Morris PJ; Wood KJ; Claas FH
    Hum Immunol; 2001 Jul; 62(7):661-7. PubMed ID: 11423171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
    Speiser DE; Löliger CC; Siren MK; Jeannet M
    Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens.
    Zhang L; Li SG; Vandekerckhove B; Termijtelen A; Van Rood JJ; Claas FH
    J Immunol Methods; 1989 Jul; 121(1):39-45. PubMed ID: 2787821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens.
    van Kampen CA; Versteeg-van der Voort Maarschalk MF; Roelen DL; ten Berge IJ; Claas FH
    Transplantation; 2001 Apr; 71(7):869-74. PubMed ID: 11349718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
    Oudshoorn M; Doxiadis II; van den Berg-Loonen PM; Voorter CE; Verduyn W; Claas FH
    Hum Immunol; 2002 Mar; 63(3):176-84. PubMed ID: 11872235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
    Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH
    J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching.
    Stobbe I; van der Meer-Prins EM; de Lange P; Oudshoorn M; Doxiadis II; Claas FH
    Hum Immunol; 2000 Sep; 61(9):879-83. PubMed ID: 11053631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.
    Bourgault I; Gomez A; Gomard E; Levy JP
    Clin Exp Immunol; 1991 Jun; 84(3):501-7. PubMed ID: 1646086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.
    Stobbe I; van der Meer-Prins E; Smits JM; Doxiadis II; Claas FH
    Transpl Immunol; 1999 Dec; 7(4):215-20. PubMed ID: 10638834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506.
    Roelen DL; van Bree FP; Schanz U; van Rood JJ; Claas FH
    Transplantation; 1993 Jul; 56(1):190-5. PubMed ID: 7687397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure.
    van Kampen CA; Roelen DL; Versteeg-van der Voort Maarschalk MF; Hoitsma AJ; Allebes WA; Claas FH
    Transplantation; 2002 Oct; 74(8):1114-9. PubMed ID: 12438956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the humoral and cytotoxic T-lymphocyte response to individual HLA class I alloantigens in highly immunized patients.
    Zhang L; van Bree S; Gijbels Y; van Veen A; van Rood JJ; Class FH
    Hum Immunol; 1991 Mar; 30(3):156-61. PubMed ID: 2055781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of an influence of the noninherited maternal HLA antigens on the alloreactive T cell repertoire in healthy individuals.
    Roelen DL; van Bree FP; van Beelen E; van Rood JJ; Claas FH
    Transplantation; 1995 Jun; 59(12):1728-33. PubMed ID: 7541578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens.
    Falkenburg JH; van Luxemburg-Heijs SA; Lim FT; Kanhai HH; Willemze R
    Ann Hematol; 1996 Apr; 72(4):260-4. PubMed ID: 8624381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-specific structural differences in the alpha 1 + alpha 2 domains determine the frequency of murine cytotoxic T cell precursors stimulated by human and murine class I molecules.
    Engelhard VH; Le AX; Holterman MJ
    J Immunol; 1988 Sep; 141(6):1835-9. PubMed ID: 3262639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.
    Dankers MK; Roelen DL; Van Der Meer-Prins EM; De Lange P; Korfage N; Smits JM; Persijn GG; Welsh KI; Doxiadis II; Claas FH
    Transplantation; 2003 Feb; 75(3):418-20. PubMed ID: 12589169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients.
    Oei FB; Welters MJ; Knoop CJ; Vaessen LM; Stegmann AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2000 Oct; 18(4):466-72. PubMed ID: 11024386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.